Biora Therapeutics Achieves ISO 13485 Certification, Demonstrating The Co's Commitment To Compliance With The Most Rigorous Global Regulatory And Quality Standards
Portfolio Pulse from Benzinga Newsdesk
Biora Therapeutics, Inc. has achieved ISO 13485:2016 certification, highlighting its commitment to global regulatory and quality standards.
September 09, 2024 | 12:13 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Biora Therapeutics has been awarded ISO 13485:2016 certification, which underscores its adherence to high global regulatory and quality standards. This certification may enhance the company's reputation and credibility in the biotech industry.
The ISO 13485:2016 certification is a significant achievement for Biora Therapeutics, as it demonstrates compliance with stringent global standards. This can positively impact investor perception and potentially lead to increased trust and partnerships, thereby positively influencing the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100